Cargando…
Duration of antibiotic therapy in critically ill patients: a randomized controlled trial of a clinical and C-reactive protein-based protocol versus an evidence-based best practice strategy without biomarkers
BACKGROUND: The rational use of antibiotics is one of the main strategies to limit the development of bacterial resistance. We therefore sought to evaluate the effectiveness of a C-reactive protein-based protocol in reducing antibiotic treatment time in critically ill patients. METHODS: A randomized...
Autores principales: | Borges, Isabela, Carneiro, Rafael, Bergo, Rafael, Martins, Larissa, Colosimo, Enrico, Oliveira, Carolina, Saturnino, Saulo, Andrade, Marcus Vinícius, Ravetti, Cecilia, Nobre, Vandack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266125/ https://www.ncbi.nlm.nih.gov/pubmed/32487263 http://dx.doi.org/10.1186/s13054-020-02946-y |
Ejemplares similares
-
Prognostic value of procalcitonin in hospitalized patients with lower
respiratory tract infections
por: Nobre, Vandack, et al.
Publicado: (2016) -
Lung Ultrasound Can Predict the Clinical Course and Severity of COVID-19 Disease
por: Ravetti, Cecilia Gómez, et al.
Publicado: (2021) -
Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers
por: Salluh, Jorge IF, et al.
Publicado: (2014) -
Compartmentalized Regulation of Pulmonary and Systemic Inflammation in Critical COVID-19 Patients
por: Santiago, Luciana, et al.
Publicado: (2023) -
Role of interleukin-3 as a prognostic marker in septic
patients
por: Borges, Isabela Nascimento, et al.
Publicado: (2018)